NO2010003I2 - Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav - Google Patents

Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav

Info

Publication number: NO2010003I2
Authority: NO; Norway
Prior art keywords: prukalopride; pharmaceutically acceptable; acid addition; addition salt; acceptable acid
Prior art date: 1994-11-24

Application number

NO2010003C

Other languages

English (en)

Other versions

NO2010003I1 (no

Original Assignee

Movetis Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-24

Filing date

2010-03-05

Publication date

2012-08-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8217407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2010003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-03-05 Application filed by Movetis Nv filed Critical Movetis Nv

2010-03-05 Publication of NO2010003I1 publication Critical patent/NO2010003I1/no

2012-08-27 Publication of NO2010003I2 publication Critical patent/NO2010003I2/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO2010003C 1994-11-24 2010-03-05 Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav NO2010003I2 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP94203421		1994-11-24
PCT/EP1995/004519 WO1996016060A1 (en)	1994-11-24	1995-11-16	Enterokinetic benzamide

Publications (2)

Publication Number	Publication Date
NO2010003I1 NO2010003I1 (no)	2010-03-05
NO2010003I2 true NO2010003I2 (no)	2012-08-27

Family

ID=8217407

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO19972143A NO312726B1 (no)	1994-11-24	1997-05-09	Enterokinetisk benzamid
NO2010003C NO2010003I2 (no)	1994-11-24	2010-03-05	Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
NO2019044C NO2019044I1 (no)	1994-11-24	2019-12-11	Dihydrobenzofurancarboksamid - forlenget SPC

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19972143A NO312726B1 (no)	1994-11-24	1997-05-09	Enterokinetisk benzamid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2019044C NO2019044I1 (no)	1994-11-24	2019-12-11	Dihydrobenzofurancarboksamid - forlenget SPC

Country Status (40)

Country	Link
US (3)	US5854260A (no)
EP (1)	EP0807110B1 (no)
JP (1)	JP3046076B2 (no)
KR (1)	KR100233489B1 (no)
CN (1)	CN1071332C (no)
AP (1)	AP777A (no)
AR (1)	AR001769A1 (no)
AT (1)	ATE217306T1 (no)
AU (1)	AU704043B2 (no)
BG (1)	BG63710B1 (no)
BR (1)	BRPI9509819B8 (no)
CA (1)	CA2205573C (no)
CY (2)	CY2296B1 (no)
CZ (1)	CZ292847B6 (no)
DE (2)	DE122010000002I1 (no)
DK (1)	DK0807110T3 (no)
EE (1)	EE03313B1 (no)
ES (1)	ES2177671T3 (no)
FI (1)	FI120147B (no)
FR (1)	FR10C0001I2 (no)
HR (1)	HRP950571B1 (no)
HU (1)	HU226560B1 (no)
IL (1)	IL116101A (no)
LU (1)	LU91644I2 (no)
MY (1)	MY112944A (no)
NL (1)	NL300435I1 (no)
NO (3)	NO312726B1 (no)
NZ (1)	NZ297753A (no)
OA (1)	OA10422A (no)
PL (1)	PL183713B1 (no)
PT (1)	PT807110E (no)
RO (1)	RO116279B1 (no)
RU (1)	RU2154643C2 (no)
SI (1)	SI0807110T1 (no)
SK (1)	SK283499B6 (no)
TR (1)	TR199501483A2 (no)
TW (1)	TW490465B (no)
UA (1)	UA59334C2 (no)
WO (1)	WO1996016060A1 (no)
ZA (1)	ZA959996B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW490465B (en) *	1994-11-24	2002-06-11	Janssen Pharmaceutica Nv	Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW402591B (en) *	1997-07-11	2000-08-21	Janssen Pharmaceutica Nv	Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
KR20010043618A (ko) *	1998-05-14	2001-05-25	사바 키스 ; 아틸라 만디 야노스 템페 ; 기울라 시미그	벤조푸란 유도체, 이를 포함하는 약제 조성물과 활성성분으로서 벤조푸란 유도체의 제조방법
AU770580B2 (en) *	1998-11-23	2004-02-26	Janssen Pharmaceutica N.V.	Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
TW592709B (en) *	1999-04-29	2004-06-21	Janssen Pharmaceutica Nv	Prucalopride oral solution
CN1288730A (zh) *	1999-09-07	2001-03-28	麦克内尔-Ppc股份有限公司	轻泻组合物
EP1467991B1 (en)	2002-01-16	2005-05-18	Janssen Pharmaceutica N.V.	Prucalopride-n-oxide
JP5797655B2 (ja) *	2009-09-18	2015-10-21	アドラー・コーポレーション	消化管障害のためのオピオイド受容体アンタゴニストの使用
GB201103397D0 (no)	2011-02-28	2011-04-13	Shire Movetis N V
CN102295594B (zh) *	2011-07-12	2016-01-20	上海医药工业研究院	4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
CA2845039A1 (en)	2011-08-18	2013-02-21	Shire Ag	Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy
WO2017137910A1 (en) *	2016-02-11	2017-08-17	Symed Labs Limited	Processes for the preparation of highly pure prucalopride succinate and its intermediates
CN108727351B (zh) *	2017-04-19	2021-08-31	鲁南制药集团股份有限公司	一种普芦卡必利的精制方法
CN119700664B (zh) *	2025-02-28	2025-06-20	山东新时代药业有限公司	含有活性成分琥珀酸普芦卡必利的注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2593504B1 (fr) *	1986-01-30	1988-12-09	Ile De France	Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
US5374637A (en) *	1989-03-22	1994-12-20	Janssen Pharmaceutica N.V.	N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) *	1990-03-06	1990-05-02	Janssen Pharmaceutica Nv	N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
GB9028105D0 (en) *	1990-12-27	1991-02-13	Erba Carlo Spa	Process for the preparation of substituted benzofuran derivatives
TW490465B (en) *	1994-11-24	2002-06-11	Janssen Pharmaceutica Nv	Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof

1995
- 1995-11-08 TW TW084111813A patent/TW490465B/zh not_active IP Right Cessation
- 1995-11-16 RO RO97-00942A patent/RO116279B1/ro unknown
- 1995-11-16 CA CA002205573A patent/CA2205573C/en not_active Expired - Lifetime
- 1995-11-16 DE DE201012000002 patent/DE122010000002I1/de active Pending
- 1995-11-16 BR BRPI9509819A patent/BRPI9509819B8/pt not_active IP Right Cessation
- 1995-11-16 DE DE69526679T patent/DE69526679T2/de not_active Expired - Lifetime
- 1995-11-16 KR KR1019970703419A patent/KR100233489B1/ko not_active Expired - Lifetime
- 1995-11-16 JP JP8516549A patent/JP3046076B2/ja not_active Expired - Lifetime
- 1995-11-16 PT PT95941613T patent/PT807110E/pt unknown
- 1995-11-16 PL PL95320297A patent/PL183713B1/pl unknown
- 1995-11-16 AT AT95941613T patent/ATE217306T1/de active
- 1995-11-16 UA UA97052121A patent/UA59334C2/uk unknown
- 1995-11-16 CZ CZ19971555A patent/CZ292847B6/cs not_active IP Right Cessation
- 1995-11-16 DK DK95941613T patent/DK0807110T3/da active
- 1995-11-16 AU AU42992/96A patent/AU704043B2/en not_active Expired
- 1995-11-16 US US08/836,276 patent/US5854260A/en not_active Expired - Lifetime
- 1995-11-16 ES ES95941613T patent/ES2177671T3/es not_active Expired - Lifetime
- 1995-11-16 HU HU9702127A patent/HU226560B1/hu active Protection Beyond IP Right Term
- 1995-11-16 SK SK652-97A patent/SK283499B6/sk not_active IP Right Cessation
- 1995-11-16 NZ NZ297753A patent/NZ297753A/en not_active IP Right Cessation
- 1995-11-16 WO PCT/EP1995/004519 patent/WO1996016060A1/en not_active Ceased
- 1995-11-16 AP APAP/P/1997/000992A patent/AP777A/en active
- 1995-11-16 SI SI9530593T patent/SI0807110T1/xx unknown
- 1995-11-16 RU RU97110232/04A patent/RU2154643C2/ru active
- 1995-11-16 CN CN95196347A patent/CN1071332C/zh not_active Expired - Lifetime
- 1995-11-16 EP EP95941613A patent/EP0807110B1/en not_active Expired - Lifetime
- 1995-11-16 EE EE9700116A patent/EE03313B1/xx not_active IP Right Cessation
- 1995-11-23 AR AR33436095A patent/AR001769A1/es unknown
- 1995-11-23 ZA ZA959996A patent/ZA959996B/xx unknown
- 1995-11-23 IL IL11610195A patent/IL116101A/xx not_active IP Right Cessation
- 1995-11-23 HR HR950571A patent/HRP950571B1/xx not_active IP Right Cessation
- 1995-11-24 MY MYPI95003617A patent/MY112944A/en unknown
- 1995-11-24 TR TR95/01483A patent/TR199501483A2/xx unknown
1997
- 1997-05-09 NO NO19972143A patent/NO312726B1/no not_active IP Right Cessation
- 1997-05-23 FI FI972203A patent/FI120147B/fi active Protection Beyond IP Right Term
- 1997-05-23 OA OA70012A patent/OA10422A/en unknown
- 1997-06-11 BG BG101605A patent/BG63710B1/bg unknown
1998
- 1998-09-24 US US09/159,993 patent/US5948794A/en not_active Expired - Lifetime
1999
- 1999-06-04 US US09/325,865 patent/US6310077B1/en not_active Expired - Lifetime
2002
- 2002-09-20 CY CY0200055A patent/CY2296B1/xx unknown
2010
- 2010-01-06 FR FR10C0001C patent/FR10C0001I2/fr active Active
- 2010-01-15 CY CY2010001C patent/CY2010001I2/el unknown
- 2010-01-27 LU LU91644C patent/LU91644I2/en unknown
- 2010-02-09 NL NL300435C patent/NL300435I1/nl unknown
- 2010-03-05 NO NO2010003C patent/NO2010003I2/no unknown
2019
- 2019-12-11 NO NO2019044C patent/NO2019044I1/no unknown

Also Published As

Publication number	Publication date
UA59334C2 (uk)	2003-09-15
KR100233489B1 (ko)	1999-12-01
SI0807110T1 (en)	2002-08-31
NO312726B1 (no)	2002-06-24
AP9700992A0 (en)	1997-07-31
ES2177671T3 (es)	2002-12-16
AU4299296A (en)	1996-06-17
NZ297753A (en)	1998-05-27
BG101605A (bg)	1998-02-27
BRPI9509819B8 (pt)	2021-07-06
CN1164233A (zh)	1997-11-05
PL320297A1 (en)	1997-09-15
CA2205573A1 (en)	1996-05-30
LU91644I2 (en)	2010-03-29
RO116279B1 (ro)	2000-12-29
ATE217306T1 (de)	2002-05-15
AP777A (en)	1999-10-28
IL116101A0 (en)	1996-01-31
PL183713B1 (pl)	2002-07-31
PT807110E (pt)	2002-10-31
FI972203A0 (fi)	1997-05-23
CA2205573C (en)	2006-05-09
NO972143D0 (no)	1997-05-09
TW490465B (en)	2002-06-11
NO2010003I1 (no)	2010-03-05
WO1996016060A1 (en)	1996-05-30
CN1071332C (zh)	2001-09-19
EP0807110A1 (en)	1997-11-19
CY2296B1 (en)	2003-07-04
TR199501483A2 (tr)	1996-07-21
DE122010000002I1 (de)	2011-12-01
OA10422A (en)	2002-03-19
SK283499B6 (sk)	2003-08-05
CY2010001I1 (el)	2010-07-28
FR10C0001I2 (fr)	2011-04-01
BRPI9509819B1 (pt)	2018-05-15
HUT77375A (hu)	1998-04-28
AU704043B2 (en)	1999-04-15
HRP950571B1 (en)	2001-12-31
DE69526679T2 (de)	2002-12-05
JPH09512832A (ja)	1997-12-22
EE03313B1 (et)	2000-12-15
JP3046076B2 (ja)	2000-05-29
FI972203L (fi)	1997-05-23
US5854260A (en)	1998-12-29
US5948794A (en)	1999-09-07
EP0807110B1 (en)	2002-05-08
RU2154643C2 (ru)	2000-08-20
NO972143L (no)	1997-05-09
AR001769A1 (es)	1997-12-10
BR9509819A (pt)	1997-09-30
HU226560B1 (en)	2009-04-28
FR10C0001I1 (no)	2010-02-12
NO2019044I1 (no)	2019-12-11
BG63710B1 (bg)	2002-10-31
DE69526679D1 (de)	2002-06-13
NL300435I1 (nl)	2010-04-01
ZA959996B (en)	1997-05-23
IL116101A (en)	1999-08-17
CZ155597A3 (en)	1997-09-17
MY112944A (en)	2001-10-31
FI120147B (fi)	2009-07-15
CZ292847B6 (cs)	2003-12-17
HRP950571A2 (en)	1997-08-31
DK0807110T3 (da)	2002-09-02
US6310077B1 (en)	2001-10-30
CY2010001I2 (el)	2010-07-28
SK65297A3 (en)	1997-10-08
MX9703869A (es)	1997-09-30

Publication	Publication Date	Title
NO2010003I2 (no)	2012-08-27	Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
NO2009004I2 (no)	2010-08-16	Mavacoxib eller et farmasøytisk akseptabelt salt derav
NO2018014I2 (no)	2018-11-19	Deferasirox eller et farmasøytisk akseptabelt salt derav
NO2009028I2 (no)	2011-10-17	Gefitinib eller et farmasøytisk akseptabelt salt derav
FI954404L (fi)	1995-09-18	Fenoksifenyylietikkahappojohdannaiset
NO2009023I2 (no)	2012-12-03	Retapamulin eller farmasøytisk akseptabelt salt derav
NO2011007I1 (no)	2011-06-06	Ticagrelor eller et farmasøytisk akseptabelt salt derav
DK0884319T3 (da)	2004-08-30	N-(1-nbutyl-4-piperidyl)methyl-3,4-dihydro-2H-1,3-oxazino-3,2a-indol-10-carboxamid eller et farmaceutisk acceptabelt salt deraf
ATE211131T1 (de)	2002-01-15	Arylsulfonylaminohydroxamsäurederivate
FI933260A7 (fi)	1994-01-22	Heteroaettiksyraderivat
NO2009007I2 (no)	2010-06-07	Robenakoksib, eller et farmasøytisk akseptabelt salt derav, eller en farmasøytisk akseptabel in vivo hydrolyserbar ester derav
NO2001002I1 (no)	2001-02-12	Lamivudin, eventuelt i form av et farmasøytisk godtgbart salt
FI951962A7 (fi)	1995-10-26	Hydroksaamihappojohdannaiset
FI945688A7 (fi)	1995-06-04	Etikkahappojohdannaisia
FI942923A7 (fi)	1994-12-25	Propeenihappojohdannaiset
FI954007A0 (fi)	1995-08-25	Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
DE59402189D1 (de)	1997-04-30	2-Keto-3-methyl-4-hydroxy-valeriansäure
FI942976A7 (fi)	1995-02-28	5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
NO950477D0 (no)	1995-02-09	Aminosyrederivater
ATE230734T1 (de)	2003-01-15	3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
EE9800186A (et)	1998-12-15	Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett
DE59402621D1 (de)	1997-06-12	Fluor-trifluormethylbenzoesäure-Derivate
FI941149L (fi)	1994-12-22	2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
FI970195A7 (fi)	1997-02-05	Trifluormetyylikinoliinikarboksyylihappojohdannainen
FI932953A7 (fi)	1993-12-27	Imidazolylsubstituerade fenylpropion- och -kanelsyraderivat